Alcon Inc (Alcon) is engaged in the development and manufacturing of devices in the field of ophthalmology. The company’s portfolio encompasses contact lenses and surgical products, including implantables, consumables and surgical equipment. The company's products are indicated for the treatment of various conditions such as cataracts, glaucoma, retinal diseases and refractive errors. It conducts clinical trials to evaluate the safety and efficacy of its products for prevention and cure of blindness and different eye diseases. Alcon’s pipeline products are developed through collaboration with institutions, medical innovators, research advisors, and academic thought leaders. The company has operations in the Americas, Europe, the Middle East, and Africa and Asia Pacific. Alcon is headquartered in Geneva, Switzerland.
Headquarters
Switzerland
Address
Rue Louis-D'Affry 6, Fribourg, 1701
Website
www.alcon.com
No of Employees
24,389
Industry
Medical Equipment
Ticker Symbol & Exchange
ALC (SWF)
Revenue (2021)
$8.3B
21.3%
(2021 vs 2020)
EPS
XXX
Net Income (2021)
XXX
170.8%
(2021 vs 2020)
Market Cap*
$33.2B
Net Profit Margin (2021)
XXX
158.4%
(2021 vs 2020)
* As of and is in US$
Explore premium data & analytics
Products and Services
| Products | Brands |
|---|---|
| Vision Care: | Total |
| Contact Lenses | Precision |
| Ocular Health Products | Systane |
| XXX | XXX |
| XXX | XXX |
| XXX | XXX |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2022 | Contracts/Agreements | In May, the company entered into an agreement to acquire EYSUVIS and INVELTYS from Kala Pharmaceuticals Inc, a commercial-stage biopharmaceutical company. |
| 2022 | Financing Agreements | In April, the company along with Petrichor Healthcare Capital Management, Flying L Partners, Falcon Vision invested US$120 million in Aurion Biotech. |
| 2022 | New Products/Services | In March, the company launched Clareon portfolio in the US. |
Competitor Comparison
| Key Parameters | Alcon Inc | Johnson & Johnson | EssilorLuxottica SA | Bausch Health Companies Inc | Konica Minolta Inc |
|---|---|---|---|---|---|
| Headquarters | Switzerland | United States of America | France | Canada | Japan |
| City | Fribourg | New Brunswick | Charenton-Le-Pont | Laval | Chiyoda-Ku |
| State/Province | - | New Jersey | - | Quebec | Tokyo |
| No. of Employees | 24,389 | 141,700 | 182,684 | 19,600 | 40,979 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Operating Margin
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| F. Michael Ball | Chairman | Executive Board | 2018 | 66 |
| David J. Endicot | Chief Executive Officer; Director | Executive Board | 2018 | 56 |
| Timothy C. Stonesifer | Chief Financial Officer; Senior Vice President | Senior Management | 2019 | 54 |
| Sue-Jean Lin | Senior Vice President; Chief Information and Transformation Officer | Senior Management | 2018 | 63 |
| Kim Martin | Senior Vice President; Chief Human Resources Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer